Multiple Sclerosis News Today reported that TG Therapeutics has set the list price for Briumvi at $59,000 per year, which is the lowest list price for any branded MS therapy currently on the market.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果当前正在显示可能无法访问的结果。
隐藏无法访问的结果